Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
Annals of Hematology|July 1, 1995
Mitoxantrone and cytosine arabinoside as treatment for acute myeloblastic leukemia in older patientsP K MacCallum, A Z Rohatiner, C L Davis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation given as a 24-hour continuous infusion weekly times four every 5 weeksL L Siu, A M Oza, E A Eisenhauer, et al.Gynecologic Oncology|December 6, 2011
A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II ConsortiaH J Mackay, R J Buckanovich, H Hirte, et al.British Journal of Cancer|March 30, 2006
Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancerC A Townsley, P Major, L L Siu, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 22, 2005
Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignanciesL H Lê, K D Swenerton, L Elit, et al.American Journal of Clinical Oncology|December 18, 1998
Phase I-II study of 5-fluorouracil, leucovorin, doxorubicin, methotrexate, and long-term oral etoposide (FLAME) in unresectable or metastatic gastric cancerG A Bjarnason, C Cripps, R Goel, et al.Cancer Chemotherapy and Pharmacology|March 11, 2006
A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials GroupG Goss, L L Siu, I Gauthier, et al.Gynecologic Oncology|February 23, 2019
Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patientsV Rodriguez-Freixinos, S Lheureux, V Mandilaras, et al.Gynecologic Oncology|January 8, 2017
Genotype-matched treatment for patients with advanced type I epithelial ovarian cancer (EOC)A Spreafico, A M Oza, B A Clarke, et al.Current Oncology (Toronto, Ont.)|October 5, 2011
Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspectiveA M Oza, V Castonguay, D Tsoref, et al.Pageof 5